14.6861 USD
+0.87 (+6.27%)
ChartMill assigns a Buy % Consensus number of 75% to STRO. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 34.53. This target is 135.15% above the current price.
- STRO was analyzed by 16 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about STRO.
- In the previous month the buy percentage consensus was at a similar level.
- STRO was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-20 | Citizens | Upgrade | Market Perform -> Market Outperform |
| 2025-12-22 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-08-12 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-16 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-05-19 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-04-29 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-17 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-03-14 | Citizens Capital Markets | Downgrade | Market Outperform -> Market Perform |
| 2025-03-14 | Wedbush | Downgrade | Outperform -> Neutral |
| 2025-03-14 | B of A Securities | Downgrade | Buy -> Underperform |
| 2024-12-11 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-11 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-10-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-16 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-14 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | B of A Securities | Initiate | Buy |
| 2024-04-03 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-04-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-03 | Truist Securities | Maintains | Buy -> Buy |
| 2024-04-03 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-03-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-26 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
SUTRO BIOPHARMA INC / STRO FAQ
What is the average price target for SUTRO BIOPHARMA INC (STRO) stock?
16 analysts have analysed STRO and the average price target is 34.53 USD. This implies a price increase of 135.15% is expected in the next year compared to the current price of 14.6861.
Can you provide the consensus rating for SUTRO BIOPHARMA INC stock?
The consensus rating for SUTRO BIOPHARMA INC (STRO) is 75 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed SUTRO BIOPHARMA INC (STRO)?
The number of analysts covering SUTRO BIOPHARMA INC (STRO) is 16.